0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and Japan Sterile Active Pharmaceutical Ingredients Market Insights, Forecast to 2027
Published Date: September 2021
|
Report Code: QYRE-Auto-38W7849
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global and Japan Sterile Active Pharmaceutical Ingredients Market Insights Forecast to 2027

Global and Japan Sterile Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

Code: QYRE-Auto-38W7849
Report
September 2021
Pages:140
QYResearch
Description
Table of Content
Tables & Figures

Sterile Active Pharmaceutical Ingredients Market

Active Pharmaceutical Ingredients (API's), used as ingredients in sterile medicinal products, must be sterile unless the final dosage form is terminally sterilised, or produced by a process including a sterilising filtration step.

This report focuses on global and Japan Sterile Active Pharmaceutical Ingredients market.

In 2020, the global Sterile Active Pharmaceutical Ingredients market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Sterile Active Pharmaceutical Ingredients market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Sterile Active Pharmaceutical Ingredients market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Sterile Active Pharmaceutical Ingredients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Sterile Active Pharmaceutical Ingredients market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

By Type

  • Aqueous
  • Non-aqueous Liquid
  • Dry Powder
  • Others

By Application

  • CNS
  • Cardiovascular
  • Genitourinary/Hormonal Drugs
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

By Company

  • Aurobindo Pharma
  • Teva Pharmaceutical Industries
  • Corden Pharma
  • Dalton Pharma Services
  • Pfizer
  • Sun Pharmaceutical Industries
  • Lonza Group
  • Albany Molecular Research
  • Sanofi
  • Reddy’s Laboratories
1 Study Coverage
1.1 Sterile Active Pharmaceutical Ingredients Product Introduction
1.2 Market by Type
1.2.1 Global Sterile Active Pharmaceutical Ingredients Market Size Growth Rate by Type
1.2.2 Aqueous
1.2.3 Non-aqueous Liquid
1.2.4 Dry Powder
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sterile Active Pharmaceutical Ingredients Market Size Growth Rate by Application
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sterile Active Pharmaceutical Ingredients Market Size, Estimates and Forecasts
2.1.1 Global Sterile Active Pharmaceutical Ingredients Revenue 2016-2027
2.1.2 Global Sterile Active Pharmaceutical Ingredients Sales 2016-2027
2.2 Global Sterile Active Pharmaceutical Ingredients, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Sterile Active Pharmaceutical Ingredients Historical Market Size by Region (2016-2021)
2.3.1 Global Sterile Active Pharmaceutical Ingredients Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Sterile Active Pharmaceutical Ingredients Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Sterile Active Pharmaceutical Ingredients Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Sterile Active Pharmaceutical Ingredients Sales Forecast by Region (2022-2027)
2.4.2 Global Sterile Active Pharmaceutical Ingredients Revenue Forecast by Region (2022-2027)
3 Global Sterile Active Pharmaceutical Ingredients Competitor Landscape by Players
3.1 Global Top Sterile Active Pharmaceutical Ingredients Manufacturers by Sales
3.1.1 Global Sterile Active Pharmaceutical Ingredients Sales by Manufacturer (2016-2021)
3.1.2 Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Sterile Active Pharmaceutical Ingredients Manufacturers by Revenue
3.2.1 Key Sterile Active Pharmaceutical Ingredients Manufacturers Covered: Ranking by Revenue
3.2.2 Global Sterile Active Pharmaceutical Ingredients Revenue by Manufacturers (2016-2021)
3.2.3 Global Sterile Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Sterile Active Pharmaceutical Ingredients Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Sterile Active Pharmaceutical Ingredients Revenue in 2020
3.2.6 Global Sterile Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Sterile Active Pharmaceutical Ingredients Price by Manufacturers
3.4 Global Sterile Active Pharmaceutical Ingredients Manufacturing Base Distribution, Product Types
3.4.1 Sterile Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sterile Active Pharmaceutical Ingredients Product Type
3.4.3 Date of International Manufacturers Enter into Sterile Active Pharmaceutical Ingredients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Sterile Active Pharmaceutical Ingredients Market Size by Type (2016-2021)
4.1.1 Global Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2021)
4.1.2 Global Sterile Active Pharmaceutical Ingredients Revenue by Type (2016-2021)
4.1.3 Sterile Active Pharmaceutical Ingredients Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Sterile Active Pharmaceutical Ingredients Market Size Forecast by Type (2022-2027)
4.2.1 Global Sterile Active Pharmaceutical Ingredients Sales Forecast by Type (2022-2027)
4.2.2 Global Sterile Active Pharmaceutical Ingredients Revenue Forecast by Type (2022-2027)
4.2.3 Sterile Active Pharmaceutical Ingredients Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Sterile Active Pharmaceutical Ingredients Market Size by Application (2016-2021)
5.1.1 Global Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2021)
5.1.2 Global Sterile Active Pharmaceutical Ingredients Revenue by Application (2016-2021)
5.1.3 Sterile Active Pharmaceutical Ingredients Price by Application (2016-2021)
5.2 Sterile Active Pharmaceutical Ingredients Market Size Forecast by Application (2022-2027)
5.2.1 Global Sterile Active Pharmaceutical Ingredients Sales Forecast by Application (2022-2027)
5.2.2 Global Sterile Active Pharmaceutical Ingredients Revenue Forecast by Application (2022-2027)
5.2.3 Global Sterile Active Pharmaceutical Ingredients Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Sterile Active Pharmaceutical Ingredients Market Size YoY Growth 2016-2027
6.1.1 Japan Sterile Active Pharmaceutical Ingredients Sales YoY Growth 2016-2027
6.1.2 Japan Sterile Active Pharmaceutical Ingredients Revenue YoY Growth 2016-2027
6.1.3 Japan Sterile Active Pharmaceutical Ingredients Market Share in Global Market 2016-2027
6.2 Japan Sterile Active Pharmaceutical Ingredients Market Size by Players (International and Local Players)
6.2.1 Japan Top Sterile Active Pharmaceutical Ingredients Players by Sales (2016-2021)
6.2.2 Japan Top Sterile Active Pharmaceutical Ingredients Players by Revenue (2016-2021)
6.3 Japan Sterile Active Pharmaceutical Ingredients Historic Market Review by Type (2016-2021)
6.3.1 Japan Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
6.3.2 Japan Sterile Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2021)
6.3.3 Japan Sterile Active Pharmaceutical Ingredients Price by Type (2016-2021)
6.4 Japan Sterile Active Pharmaceutical Ingredients Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Sterile Active Pharmaceutical Ingredients Sales Forecast by Type (2022-2027)
6.4.2 Japan Sterile Active Pharmaceutical Ingredients Revenue Forecast by Type (2022-2027)
6.4.3 Japan Sterile Active Pharmaceutical Ingredients Price Forecast by Type (2022-2027)
6.5 Japan Sterile Active Pharmaceutical Ingredients Historic Market Review by Application (2016-2021)
6.5.1 Japan Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
6.5.2 Japan Sterile Active Pharmaceutical Ingredients Revenue Market Share by Application (2016-2021)
6.5.3 Japan Sterile Active Pharmaceutical Ingredients Price by Application (2016-2021)
6.6 Japan Sterile Active Pharmaceutical Ingredients Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Sterile Active Pharmaceutical Ingredients Sales Forecast by Application (2022-2027)
6.6.2 Japan Sterile Active Pharmaceutical Ingredients Revenue Forecast by Application (2022-2027)
6.6.3 Japan Sterile Active Pharmaceutical Ingredients Price Forecast by Application (2022-2027)
7 North America
7.1 North America Sterile Active Pharmaceutical Ingredients Market Size YoY Growth 2016-2027
7.2 North America Sterile Active Pharmaceutical Ingredients Market Facts & Figures by Country
7.2.1 North America Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021)
7.2.2 North America Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Sterile Active Pharmaceutical Ingredients Market Size YoY Growth 2016-2027
8.2 Asia Pacific Sterile Active Pharmaceutical Ingredients Market Facts & Figures by Region
8.2.1 Asia Pacific Sterile Active Pharmaceutical Ingredients Sales by Region (2016-2021)
8.2.2 Asia Pacific Sterile Active Pharmaceutical Ingredients Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Sterile Active Pharmaceutical Ingredients Market Size YoY Growth 2016-2027
9.2 Europe Sterile Active Pharmaceutical Ingredients Market Facts & Figures by Country
9.2.1 Europe Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021)
9.2.2 Europe Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Sterile Active Pharmaceutical Ingredients Market Size YoY Growth 2016-2027
10.2 Latin America Sterile Active Pharmaceutical Ingredients Market Facts & Figures by Country
10.2.1 Latin America Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021)
10.2.2 Latin America Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sterile Active Pharmaceutical Ingredients Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Sterile Active Pharmaceutical Ingredients Market Facts & Figures by Country
11.2.1 Middle East and Africa Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021)
11.2.2 Middle East and Africa Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Aurobindo Pharma
12.1.1 Aurobindo Pharma Corporation Information
12.1.2 Aurobindo Pharma Description and Business Overview
12.1.3 Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Products Offered
12.1.5 Aurobindo Pharma Recent Development
12.2 Teva Pharmaceutical Industries
12.2.1 Teva Pharmaceutical Industries Corporation Information
12.2.2 Teva Pharmaceutical Industries Description and Business Overview
12.2.3 Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Products Offered
12.2.5 Teva Pharmaceutical Industries Recent Development
12.3 Corden Pharma
12.3.1 Corden Pharma Corporation Information
12.3.2 Corden Pharma Description and Business Overview
12.3.3 Corden Pharma Sterile Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Corden Pharma Sterile Active Pharmaceutical Ingredients Products Offered
12.3.5 Corden Pharma Recent Development
12.4 Dalton Pharma Services
12.4.1 Dalton Pharma Services Corporation Information
12.4.2 Dalton Pharma Services Description and Business Overview
12.4.3 Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Products Offered
12.4.5 Dalton Pharma Services Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Description and Business Overview
12.5.3 Pfizer Sterile Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Sterile Active Pharmaceutical Ingredients Products Offered
12.5.5 Pfizer Recent Development
12.6 Sun Pharmaceutical Industries
12.6.1 Sun Pharmaceutical Industries Corporation Information
12.6.2 Sun Pharmaceutical Industries Description and Business Overview
12.6.3 Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Products Offered
12.6.5 Sun Pharmaceutical Industries Recent Development
12.7 Lonza Group
12.7.1 Lonza Group Corporation Information
12.7.2 Lonza Group Description and Business Overview
12.7.3 Lonza Group Sterile Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Lonza Group Sterile Active Pharmaceutical Ingredients Products Offered
12.7.5 Lonza Group Recent Development
12.8 Albany Molecular Research
12.8.1 Albany Molecular Research Corporation Information
12.8.2 Albany Molecular Research Description and Business Overview
12.8.3 Albany Molecular Research Sterile Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Albany Molecular Research Sterile Active Pharmaceutical Ingredients Products Offered
12.8.5 Albany Molecular Research Recent Development
12.9 Sanofi
12.9.1 Sanofi Corporation Information
12.9.2 Sanofi Description and Business Overview
12.9.3 Sanofi Sterile Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sanofi Sterile Active Pharmaceutical Ingredients Products Offered
12.9.5 Sanofi Recent Development
12.10 Dr. Reddy’s Laboratories
12.10.1 Dr. Reddy’s Laboratories Corporation Information
12.10.2 Dr. Reddy’s Laboratories Description and Business Overview
12.10.3 Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Products Offered
12.10.5 Dr. Reddy’s Laboratories Recent Development
12.11 Aurobindo Pharma
12.11.1 Aurobindo Pharma Corporation Information
12.11.2 Aurobindo Pharma Description and Business Overview
12.11.3 Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Products Offered
12.11.5 Aurobindo Pharma Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Sterile Active Pharmaceutical Ingredients Industry Trends
13.2 Sterile Active Pharmaceutical Ingredients Market Drivers
13.3 Sterile Active Pharmaceutical Ingredients Market Challenges
13.4 Sterile Active Pharmaceutical Ingredients Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Sterile Active Pharmaceutical Ingredients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Sterile Active Pharmaceutical Ingredients Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Aqueous
    Table 3. Major Manufacturers of Non-aqueous Liquid
    Table 4. Major Manufacturers of Dry Powder
    Table 5. Major Manufacturers of Others
    Table 6. Global Sterile Active Pharmaceutical Ingredients Market Size Growth Rate by Application (2021-2027) & (Kiloton)
    Table 7. Global Sterile Active Pharmaceutical Ingredients Market Size by Region (Kiloton) & (US$ Million), 2016 VS 2021 VS 2027
    Table 8. Global Sterile Active Pharmaceutical Ingredients Sales by Regions (2016-2021) & (Kiloton)
    Table 9. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Regions (2016-2021)
    Table 10. Global Sterile Active Pharmaceutical Ingredients Revenue by Regions (2016-2021) & (US$ Million)
    Table 11. Global Sterile Active Pharmaceutical Ingredients Sales Forecast by Region (2022-2027) & (Kiloton)
    Table 12. Global Sterile Active Pharmaceutical Ingredients Sales Market Share Forecast by Region (2022-2027)
    Table 13. Global Sterile Active Pharmaceutical Ingredients Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 14. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share Forecast by Region (2022-2027)
    Table 15. Global Sterile Active Pharmaceutical Ingredients Sales by Manufacturers (2016-2021) (Kiloton)
    Table 16. Global Sterile Active Pharmaceutical Ingredients Sales Share by Manufacturers (2016-2021)
    Table 17. Ranking of Global Top Sterile Active Pharmaceutical Ingredients Manufacturers by Revenue (US$ Million) in 2020
    Table 18. Sterile Active Pharmaceutical Ingredients Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 19. Sterile Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2016-2021)
    Table 20. Global Sterile Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 21. Global Sterile Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sterile Active Pharmaceutical Ingredients as of 2020)
    Table 22. Key Manufacturers Sterile Active Pharmaceutical Ingredients Price (2016-2021) (US$/Ton)
    Table 23. Sterile Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Sterile Active Pharmaceutical Ingredients Product Type
    Table 25. Date of International Manufacturers Enter into Sterile Active Pharmaceutical Ingredients Market
    Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 27. Global Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2021) (Kiloton)
    Table 28. Global Sterile Active Pharmaceutical Ingredients Sales Share by Type (2016-2021)
    Table 29. Global Sterile Active Pharmaceutical Ingredients Revenue by Type (2016-2021) (US$ Million)
    Table 30. Global Sterile Active Pharmaceutical Ingredients Revenue Share by Type (2016-2021)
    Table 31. Sterile Active Pharmaceutical Ingredients Average Selling Price (ASP) by Type (2016-2021) & (US$/Ton)
    Table 32. Global Sterile Active Pharmaceutical Ingredients Sales Forecast by Type (2022-2027) & (Kiloton)
    Table 33. Global Sterile Active Pharmaceutical Ingredients Sales Market Share Forecast by Type (2022-2027)
    Table 34. Global Sterile Active Pharmaceutical Ingredients Revenue Forecast V (2022-2027) & (US$ Million)
    Table 35. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share Forecast by Type (2022-2027)
    Table 36. Global Sterile Active Pharmaceutical Ingredients Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Ton)
    Table 37. Global Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2021) (Kiloton)
    Table 38. Global Sterile Active Pharmaceutical Ingredients Sales Share by Application (2016-2021)
    Table 39. Global Sterile Active Pharmaceutical Ingredients Revenue by Application (2016-2021) (US$ Million)
    Table 40. Global Sterile Active Pharmaceutical Ingredients Revenue Share by Application (2016-2021)
    Table 41. Sterile Active Pharmaceutical Ingredients Average Selling Price (ASP) by Application (2016-2021) & (US$/Ton)
    Table 42. Global Sterile Active Pharmaceutical Ingredients Sales Forecast by Application (2022-2027) & (Kiloton)
    Table 43. Global Sterile Active Pharmaceutical Ingredients Sales Market Share Forecast by Application (2022-2027)
    Table 44. Global Sterile Active Pharmaceutical Ingredients Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 45. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share Forecast by Application (2022-2027)
    Table 46. Global Sterile Active Pharmaceutical Ingredients Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Ton)
    Table 47. Japan Sterile Active Pharmaceutical Ingredients Sales (Kiloton) of Key Companies (2016-2021)
    Table 48. Japan Sterile Active Pharmaceutical Ingredients Sales Share by Company (2016-2021)
    Table 49. Japan Sterile Active Pharmaceutical Ingredients Revenue (US$ Million) by Company (2016-2021)
    Table 50. Japan Sterile Active Pharmaceutical Ingredients Revenue Share by Company (2016-2021)
    Table 51. Japan Sterile Active Pharmaceutical Ingredients Sales (Kiloton) by Type (2016-2021)
    Table 52. Japan Sterile Active Pharmaceutical Ingredients Sales Share by Type (2016-2021)
    Table 53. Japan Sterile Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 54. Japan Sterile Active Pharmaceutical Ingredients Price (US$/Ton) by Type (2016-2021)
    Table 55. Japan Sterile Active Pharmaceutical Ingredients Sales (Kiloton) by Type (2022-2027)
    Table 56. Japan Sterile Active Pharmaceutical Ingredients Sales Share by Type (2022-2027)
    Table 57. Japan Sterile Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 58. Japan Sterile Active Pharmaceutical Ingredients Revenue Share by Type (2022-2027)
    Table 59. Japan Sterile Active Pharmaceutical Ingredients Price (US$/Ton) by Type (2022-2027)
    Table 60. Japan Sterile Active Pharmaceutical Ingredients Sales (Kiloton) by Application (2016-2021)
    Table 61. Japan Sterile Active Pharmaceutical Ingredients Sales Share by Application (2016-2021)
    Table 62. Japan Sterile Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 63. Japan Sterile Active Pharmaceutical Ingredients Price (US$/Ton) by Application (2016-2021)
    Table 64. Japan Sterile Active Pharmaceutical Ingredients Sales (Kiloton) by Application (2022-2027)
    Table 65. Japan Sterile Active Pharmaceutical Ingredients Sales Share by Application (2022-2027)
    Table 66. Japan Sterile Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 67. Japan Sterile Active Pharmaceutical Ingredients Revenue Share by Application (2022-2027)
    Table 68. Japan Sterile Active Pharmaceutical Ingredients Price (US$/Ton) by Application (2022-2027)
    Table 69. North America Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
    Table 70. North America Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
    Table 71. North America Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
    Table 72. North America Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
    Table 73. Asia Pacific Sterile Active Pharmaceutical Ingredients Sales by Region (2016-2021) & (Kiloton)
    Table 74. Asia Pacific Sterile Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
    Table 75. Asia Pacific Sterile Active Pharmaceutical Ingredients Revenue by Region (2016-2021) & (US$ Million)
    Table 76. Asia Pacific Sterile Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
    Table 77. Europe Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
    Table 78. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
    Table 79. Europe Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
    Table 80. Europe Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
    Table 81. Latin America Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
    Table 82. Latin America Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
    Table 83. Latin Americaa Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
    Table 84. Latin America Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
    Table 86. Middle East and Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
    Table 87. Middle East and Africa Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
    Table 88. Middle East and Africa Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
    Table 89. Aurobindo Pharma Corporation Information
    Table 90. Aurobindo Pharma Description and Business Overview
    Table 91. Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 92. Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Product
    Table 93. Aurobindo Pharma Recent Development
    Table 94. Teva Pharmaceutical Industries Corporation Information
    Table 95. Teva Pharmaceutical Industries Description and Business Overview
    Table 96. Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 97. Teva Pharmaceutical Industries Product
    Table 98. Teva Pharmaceutical Industries Recent Development
    Table 99. Corden Pharma Corporation Information
    Table 100. Corden Pharma Description and Business Overview
    Table 101. Corden Pharma Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 102. Corden Pharma Product
    Table 103. Corden Pharma Recent Development
    Table 104. Dalton Pharma Services Corporation Information
    Table 105. Dalton Pharma Services Description and Business Overview
    Table 106. Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 107. Dalton Pharma Services Product
    Table 108. Dalton Pharma Services Recent Development
    Table 109. Pfizer Corporation Information
    Table 110. Pfizer Description and Business Overview
    Table 111. Pfizer Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 112. Pfizer Product
    Table 113. Pfizer Recent Development
    Table 114. Sun Pharmaceutical Industries Corporation Information
    Table 115. Sun Pharmaceutical Industries Description and Business Overview
    Table 116. Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 117. Sun Pharmaceutical Industries Product
    Table 118. Sun Pharmaceutical Industries Recent Development
    Table 119. Lonza Group Corporation Information
    Table 120. Lonza Group Description and Business Overview
    Table 121. Lonza Group Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 122. Lonza Group Product
    Table 123. Lonza Group Recent Development
    Table 124. Albany Molecular Research Corporation Information
    Table 125. Albany Molecular Research Description and Business Overview
    Table 126. Albany Molecular Research Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 127. Albany Molecular Research Product
    Table 128. Albany Molecular Research Recent Development
    Table 129. Sanofi Corporation Information
    Table 130. Sanofi Description and Business Overview
    Table 131. Sanofi Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 132. Sanofi Product
    Table 133. Sanofi Recent Development
    Table 134. Dr. Reddy’s Laboratories Corporation Information
    Table 135. Dr. Reddy’s Laboratories Description and Business Overview
    Table 136. Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 137. Dr. Reddy’s Laboratories Product
    Table 138. Dr. Reddy’s Laboratories Recent Development
    Table 139. Sterile Active Pharmaceutical Ingredients Market Trends
    Table 140. Sterile Active Pharmaceutical Ingredients Market Drivers
    Table 141. Sterile Active Pharmaceutical Ingredients Market Challenges
    Table 142. Sterile Active Pharmaceutical Ingredients Market Restraints
    Table 143. Sterile Active Pharmaceutical Ingredients Customers List
    Table 144. Sterile Active Pharmaceutical Ingredients Distributors List
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sterile Active Pharmaceutical Ingredients Product Picture
    Figure 2. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Type in 2020 & 2027
    Figure 3. Aqueous Product Picture
    Figure 4. Non-aqueous Liquid Product Picture
    Figure 5. Dry Powder Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Application in 2020 & 2027
    Figure 8. CNS
    Figure 9. Cardiovascular
    Figure 10. Genitourinary/Hormonal Drugs
    Figure 11. Respiratory
    Figure 12. Rheumatology
    Figure 13. Diabetes
    Figure 14. Oncology
    Figure 15. Others
    Figure 16. Sterile Active Pharmaceutical Ingredients Report Years Considered
    Figure 17. Global Sterile Active Pharmaceutical Ingredients Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 18. Global Sterile Active Pharmaceutical Ingredients Market Size 2016-2027 (US$ Million)
    Figure 19. Global Sterile Active Pharmaceutical Ingredients Sales 2016-2027 (Kiloton)
    Figure 20. Global Sterile Active Pharmaceutical Ingredients Market Size Market Share by Region: 2021 Versus 2027
    Figure 21. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
    Figure 22. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Region in 2020
    Figure 23. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
    Figure 24. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Region in 2020
    Figure 25. Global Sterile Active Pharmaceutical Ingredients Sales Share by Manufacturer in 2020
    Figure 26. The Top 10 and 5 Players Market Share by Sterile Active Pharmaceutical Ingredients Revenue in 2020
    Figure 27. Sterile Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 28. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
    Figure 29. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
    Figure 30. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2021)
    Figure 31. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Type in 2020
    Figure 32. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
    Figure 33. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
    Figure 34. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Application (2016-2021)
    Figure 35. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Application in 2020
    Figure 36. Japan Sterile Active Pharmaceutical Ingredients Sales Growth Rate 2016-2027 (Kiloton)
    Figure 37. Japan Sterile Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 38. Japan Sterile Active Pharmaceutical Ingredients Market Share in Global Market 2016-2027
    Figure 39. Japan 5 and 10 Largest Sterile Active Pharmaceutical Ingredients Players Market Share by Revenue in Sterile Active Pharmaceutical Ingredients in 2020
    Figure 40. Japan Sterile Active Pharmaceutical Ingredients Revenue Share by Type (2016-2021)
    Figure 41. Japan Sterile Active Pharmaceutical Ingredients Revenue Growth Rate by Type in 2016 & 2020
    Figure 42. Japan Sterile Active Pharmaceutical Ingredients Revenue Share by Application (2016-2021)
    Figure 43. Japan Sterile Active Pharmaceutical Ingredients Revenue Growth Rate by Application in 2016 & 2020
    Figure 44. North America Sterile Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (Kiloton)
    Figure 45. North America Sterile Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 46. North America Sterile Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
    Figure 47. North America Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
    Figure 48. United States Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 49. United States Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 50. Canada Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 51. Canada Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 52. Europe Sterile Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (Kiloton)
    Figure 53. Europe Sterile Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 54. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
    Figure 55. Europe Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
    Figure 56. Germany Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 57. Germany Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 58. France Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 59. France Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 60. U.K. Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 61. U.K. Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 62. Italy Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 63. Italy Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 64. Russia Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 65. Russia Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 66. Asia Pacific Sterile Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (Kiloton)
    Figure 67. Asia Pacific Sterile Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 68. Asia Pacific Sterile Active Pharmaceutical Ingredients Sales Market Share by Region in 2020
    Figure 69. Asia Pacific Sterile Active Pharmaceutical Ingredients Revenue Market Share by Region in 2020
    Figure 70. China Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 71. China Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 72. Japan Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 73. Japan Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 74. South Korea Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 75. South Korea Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 76. India Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 77. India Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 78. Australia Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 79. Australia Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 80. China Taiwan Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 81. China Taiwan Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 82. Indonesia Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 83. Indonesia Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 84. Thailand Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 85. Thailand Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 86. Malaysia Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 87. Malaysia Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 88. Latin America Sterile Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (Kiloton)
    Figure 89. Latin America Sterile Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 90. Latin America Sterile Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
    Figure 91. Latin America Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
    Figure 92. Mexico Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 93. Mexico Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 94. Brazil Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 95. Brazil Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 96. Argentina Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 97. Argentina Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 98. Middle East and Africa Sterile Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (Kiloton)
    Figure 99. Middle East and Africa Sterile Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 100. Middle East and Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
    Figure 101. Middle East and Africa Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
    Figure 102. Turkey Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 103. Turkey Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 104. Saudi Arabia Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 105. Saudi Arabia Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 106. UAE Sterile Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (Kiloton)
    Figure 107. UAE Sterile Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 108. Sterile Active Pharmaceutical Ingredients Value Chain
    Figure 109. Channels of Distribution
    Figure 110. Distributors Profiles
    Figure 111. Bottom-up and Top-down Approaches for This Report
    Figure 112. Data Triangulation
    Figure 113. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3900

This license allows only one user to access the PDF.
Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart